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Abstract
MC-induced sarcomas produced under the skin on the back between&#x3000;scapulas of
C3H mice were transplanted&#x3000;succeively to the mice of the&#x3000;same strain. Us-
ing the first and the second generation tumors, viable&#x3000;tumor cells were prepared and
with these tumor cells C3H mice were&#x3000;inoculated. From these sensitized mice regional
lymph&#x3000;nodes were taken&#x3000;out at certain intervals and lymph-node cells were pre-
pared. These tumor&#x3000;cells were mixed with regional lymph-node cells in the ratio of 1 :
10, and the mixed cells were transplanted subcutaneously on the back of C3H&#x3000;mice, and
the development and growth of tumors were observed at intervals.&#x3000;As a result it was
found that the inhibitory effect of these regional&#x3000;lymph-node cells on the tumor growth
was strong one to two weeks after&#x3000;the transplantation, but beyond 3, or 4 weeks no in-
hibition&#x3000;was observable.&#x3000;In connection with the present in vivo experiments,
some comments&#x3000;were made on the available literature, and it has been demonstrated
that&#x3000;even in the cancer-bearing animal destined to die of tumors, at certain stage of cancer
there is seen an inhibitory effect of the host on the tumor&#x3000;growth by way of the lymphoid
system and that such a response of the&#x3000;host in vivo seems to be&#x3000;correlated well
with in vitro reaction.
∗PMID: 4247892 [PubMed - indexed for MEDLINE] Copyright c©OKAYAMA UNIVERSITY
MEDICAL SCHOOL
Acta Merl. Okayama 24, 161-173 (1970)
INHIBITORY EFFECT OF ISOLOGOUS REGIONAL LYMPH-
NODE CELLS FROM THE METHYLCHOLANTHRENE-
INDUCED SARCOMA BEARING MICE ON THE
TUMOR IN VIVO
Eiji KASHIHARA
Department of Surgery, Okayama University Medical School, Okayama, JaPan
(Director: Prof. S. Tanaka)
Received for publication, November 26, 1969
Reports are already available concerning the antigens that are present
in tumors induced by oncogenic virus or chemical carcinogens, but they
are lacking in the host 0,2,3). The majority of these antigens are identi.
fied by the transplantability and the manner of proliferation of viable
tumor cells in the host after isotransplantation. Namely, after isotrans.
plantation of experimentally induced tumor to superimmunize the host,
the tumors grown to a certain size are either ligated or taken out, or
heavily irradiated tumor cells are transplanted, and then viable tumor
cells are transplanted to these animals to determine their transplantability
and proliferation (3, 4, 5, 19). At the present, we have no unequivocable
evidence to prove whether or not antitumor activity is at work on the
tumors of the cancer bearing host in which cancer is aggravating, identi·
cally in the same manner as in the highly immunized animal. With
purposes to clarify this problem, HARA (3) and SATOH (7) of our labo.
ratory have performed transplantation experiments of Ehrlich cancer and
A.cells (established mammary cancer cells) in vivo and in vitro and fonnd
that even in such mice destined to die of tumors there appears at relatively
early stage of cancer, antitumor activity against its own tumors by virtue
of immunological mechanism working from the lymphoid system.
However, in these studies of the isotransplanted cancer as well as
homotransplanted cancer of established strain, it seems that in all pro-
bability, aside from tumor specific antigen, genetic differences would
intervene strongly between the host and cancer so that it would be not
sufficient to elucidate the immune reaction (antitumorgenicity) of the host
against tumor antigens by their studies alone.
In view of this, we studied the correlation between the tumor prolife-
ration and the antitumorgenicity of cancer-bearing mice. In these experi-
ments first we produced methylcholanthrene (Me). induced tumors by
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inoculating MC, a chemical carcinogen known to induce in mice tumors
with strong tumor specific antigens, and successively isotransplantations
of these MC-induced tumors had been carried out into mice. Next, using
the first and second transplants when tumor antigens would most likely
have not undergone any alteration, the isotransplantations were conducted
again. As a result we have been able to demonstrate that at a certain
stage of cancer growth clearly there occurs antitumor activity in the tumor
bearing host.
MATERIALS AND METHODS
Animals: The animals used were C3H male mice (H-2k), weighing about
20 g, 2 to 3 months old, and supplied from the Okayama University Mouse
Colony.
Carcinogen: The carcinogen in the experiments was a chemical agent of
aromatic carbohydrate, 20-methylcholanthrene (MC) which was suspended 10
arabian gum and used.
Experimental tumors: By the subcutaneous injection of 1 mg/mouse MC to
mice on the back between scapulas MC.induced tumors were produced, and
3-4 months later when the MC-induced sarcomas grew to the size of 1 cm in
diameter there were taken out and sucecssively transplanted.
Preparation of free tumor cells: By a modification of MADDEN and BURK's
method (1) the tumors of the first and second transplants in successive series are
excised, cut into fine sections, and left standing in the cold 0.2 % trypsin solution
mixed Hanks solution containing a few droplets of 0.04 % DNase for about two
hours, while shaking occasionally. Next, after discarding the supernatant a fresh
0.2 % trypsin solution containing a few droplets of DNase was added, stirred for
one hour with a magnetic stirrer, filtered through the 80-mesh filter, centrifuged
at I, 000 rpm for 10 minutes, and free sarcoma cells were taken out and the
numbers of nuclei were counted. The percentage of viable cells thus obtained
proved to be 90-95 % by the trypan blue test.
Preparation of lymph node cells: Under the skin on the back between scapulas of
C3H mice 500 x 104 cells/mouse of the first and the second transplants MC.in-
duced tumor cells were transplanted, at certain intervals regional non.metastatic
lymph nodes (superficial and deep lymph nodes of the neck, axilla and the upper
arm on both sides) were excised, finely sliced, immersed in Hank's solution to
have cell suspension, then centrifuged at 2,000 rpm for 5 minutes, and washed,
repeating the procedures 3 times to obtain free lymph node cells to be used for
the neutralization test. For the control groups, lymph nodes from the same
regions of normal C3H mice were taken out and subjected to the identical treat-
ments as with cancer-bearing mice to serve as the controls (normal lymph node
cell suspensions).
2
Acta Medica Okayama, Vol. 24 [1970], Iss. 2, Art. 4
http://escholarship.lib.okayama-u.ac.jp/amo/vol24/iss2/4
Inhibitory Effect of Lymph Node Cells on Mouse Tumor
EXPERIMENTS
163
Exp. 1: Determination of successively transplantable sarcoma cell num·
bers.
Viable sarcoma cells prepared by the above-mentioned method of
MADDEN and BURK were divided into five groups; 5x 10· cells/ml, 1 X 105
cells/ ml, 2 x 105 cells/ ml, 4 x 105 cells/ ml, and 11 X 105 cells/ ml, and each
milliliter of them was transplanted to C3H mice on the back under the
skin between scapulas to determine successively transplantable cell num-
bers.
Exp. 2: Antitumorgenicity of regional lymph nodes from cancer-bearing
mice
At everyone, two, 3, 4 and 8 weeks after the MC-induced-sarcoma
cell transplantation 3-4 mice each were sacrificed, regional lymph nodes
collected, and lymph node cells were prepared to be used for the neutrali-
zation test. Namely, the test groups are divided into 5 groups of 10 mice
each, and at. first 2 X 105 cells/ml, the minimum, successively transplan-
table sarcoma cell numbers as determined in Exp. 1, is added 2 x 106
lymph node cells/ml obtained, 1, 2, 3, 4, and 8 weeks after the transplan-
tation from respective groups of cancer-bearing mice, and the mixture is
transplanted subcutaneously on the back of C3H mice of each group.
Each group always has its control in which sarcoma cells alone are trans-
planted. As for the control groups the mixture of normal mouse lymph
node cells plus sarcoma cells in the same ratios as in the test groups is
transplanted subcutaneously on the back of C3H mice in respective
groups. The growth of cancer is estimated periodically; namely, the time
required for the tumor to grow palpable and the growth thereafter by a
calibrator.
Exp. 3: Antitumor activity of regional lymph nodes from the mice
removed of tumors
By transplanting 100 X 10· cells/mouse of MC sarcoma cells to C3H
mouse subcutaneously on the back, about 20 days later when the tumor
grew to I cm in diameter, it was excised. One week after the tumor
removal regional lymph node cells were prepared from the same mouse
and these cells were mixed with sarcoma cells in the same proportion as
in Exp. 2, and transplanted on the back of C3H mouse, and observations
on the growth of tumors were done in the same manner as in the preced-
ing experiment.
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RESULTS
Exp. 1 The determination of successively transplantable sarcoma cell numberJ
The percentage of transplantablility of Me-induced saromas of the
first and the second generations is as shown in Table 1. When the viable
Table 1. RELATION BETWEEN THE INOCULATED TUMOR CELL NUMBER AND
THE TUMOR DEVELOPMENT
Tumor cell number inoculated
5X 104/cc
1X 105/cc
2X 105/cc
4X 105/cc
11 X 105/cc
Number percent of tumor developing animals
50 % (4/8)
75 % (6/8)
90 % (9/10)
100 % (6/6)
100 % (5/5)
Note: In each experiment the same tumor cell suspension was used.
sarcoma cells are subcutaneously transplanted in the numbers over 2 X 10;
cells/mouse, in more than 90 % of the mice tumor takes hold and grows,
leading the mice to death from tumors.
Exp. 2 Antitumorgenicity of regional lymph-node cells from cancer-bearing mice
The time required for the tumors to grow palpable and the growth
curves in the cases of those mice transplanted with the mixture of sarcoma
cells plus lymph node cells from cancer.bearing mice, and with the mixture
of sarcoma cells plus normal untreated mouse lymph node cells are shown
in Figs. 1-6. Fig. 1 illustrates the data from the groups given the mixture
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Fig. 1 Gro .ving curves of the Me-induced sarcoma cells inoculated by mi;:-
ing with or without lymph node cells from untreated normal mouse
Solid lines: Tumors developed from the sarcoma cell inoculant without lymph
node cells
Broken lines: Tumors from the sarcoma cells mixed with normal lymph node
cells (four out of five animals developed tumors in both series of experiments)
+ : Death
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of untreated normal mouse lymph node cells. In this:instance just as in the
group transplanted with tumor cells only, 4 mice of the five show the
growth of tumors, indicating that normal mouse lymph node cells have no
antitumorgenicity. Figs. 2 and 3 illustrate the results of the cases given
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Fig. 2 Growth curves of the tumors after the inoculation of the MC-in-
duced sarcoma cells with or without lymph node cells from the tumor bearing
animals, one week after the tumor transplantation
Solid lines: Tumors developed from the tumor inoculant without lymph node
cells (three out of four animals developed tumors)
Broken lines: Tumors developed from the tumor cells inoculated with lymph node
cells from the tumor bearing animal (two out of four animals developed tumors)
+ : Death
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Fig. 3 Growth curves of the tumors after the inoculation of the MC-induced
sarcoma cells with or without lymph node cells from the tumor bearing animals,
two weeks after the tumor transplantation
Solid lines; Tumors developed from the tumor inoculant without lymph node
cells (three out of five animals developed tumors)
Broken lines: Tumors developed from the tumor cells inoculated with lymph node
cells from the tumor bearing animal (one out of five animals developed tumors)
+ : Death
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Fig. 4 Growth curves of the tumors after the inoculation of the MC-in-
duced sarcoma cells with or without lymph node cells from the tumor bearing
animals, three weeks after the tumor transplantation
Solid lines: Tumors developed from the tumor inoculant without lymph node
cells (three out of four animals developed tumors)
Broken lines: Tumors developed from the tumor cells inoculated with lymph node
cells from the tumor bearing animal (tv. 0 out of three animals developed tumors)
+ : Death
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Fig. 5 GroNth curves of the tumors after the inoculation of the MC-in-
duced sarcoma cells with or without lymph node cells from the tumor bearing
animals, four weeks after the tumor transplantation
Solid lines: Tumors develo;Jed from the tumor inoculant without l/m?h node
cells (five out of five animals developed tumors)
Broken lines: Tumors developed from the tumor cells inoculated with lymph node
cells from the tumor bearing animal (five out of five animals developed tumors)
+ : Death
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the mixture of lymhnode cells obtained one and two weeks after tumor
transplantation. In contrast to the controls where three mice of the four
and three mice of the 5 transplanted with sarotma cells alone respectively
show tumor growth, with corresponding test groups receiving the mixture
of the first week lymph node cells only two mice of the four and only one
out of the five mice given the mixture of the second week lymph node cells
reveal the transplantability and tumor growth. In addition, in the group
transpanted with the first week lymph node cells the time required for the
tumor to be palpable and the survival time are prolonged as compared
with the control. Figs. 4, 5, and 6 respectively show the results of those
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Fig. 6 Growth curves of the tumors after the inoculation of the MC in-
duced sarcoma cells with or without lymph node cells from the tumor bearing
animals, eight weeks after the tumor transplantation
Solid lines: Tumors developed from the tumor inoculant without lymph node
cells (four out of five animals developed tumors)
Broken lines: Tumors developed from the tumor cells inoculated with lymph node
cells from the tumor bearing animal (two out of four animals developed tumors)
+: Death
groups given the mixture of the third, fourth and eighth week lymph node
cells, and the tumor cells. In the group given the mixture of the third
week lymph node cells two mice out of three, and five out of five given
the fourth week lymph node cells show the survival and the growth of
tumor, which hardly differ from the controls receiving only tumor cells.
In the cases receiving the regional lymph node cells of thn eighth
week after transplantation plus tumor cells, two mice of the four had
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tumors developed differing from the controls receiving sarcoma cells alone
where 4 mice of the five had developed tumors, whereas there is no
difference in the time required for the tumors to become palpable and the
length of survival of the host, indicating that the regional lymph node
cells of mice 8 weeks after transplantation have lost antitumor activity.
Exp. 3 Antitumor activity of regional lymph node cells from the mice removed of
tumors
In the group receiving the transplantation of sarcoma cells alone 4
mice out of the five reveal the tumor transplantability, and in the group
receiving the mixture of sarcoma cells plus mouse regional lymph node
cells one week after the removal of tumors two mice out of the 5 show the
tumor development. Further, the death from tumor takes place two and
half months after the onset of tumor in these groups.
From these findings it is evidint that in the regional mouse lymph-
node cells of the first week and the second week mixed with tumor cells a
strong antitumor activity can be observed. Such regional lymph-node cells
of later than the fourth week show no antitumor activity, but in the group
receiving the mixed transplantation of such regional lymph-node cells with
sarcoma cells there can be seen no tendency rather to accelerate the tumor
growth in the host animals. The regional lymph-node cells of the mouse
extracted of its tumors exhibited a stronger antitumor activity than that
of the regional lymph node cells of cancer-bearing mouse.
DISCUSSION
Up to the present most of the tumors used in immunological studies
of cancer are tumors of established strain maintained successively for a
long period of time, and such tumors are transplanted to animals for
immunization. However, when the tumor is maintained successively for
a long time, there occurs alteration in its antigenicity so that a specific
tumor is converted to a non-specific one. Therefore, even when such a
tumor is transplanted to the animals of oncogenic strain, an immuno-
genetic factor other than cancer specific antigen inevitably intervenes
between the host and the cancer transplant as to make the presence of
truly specific immunity of cancer dubious (1, 2, 26). Even Me-induced
sarcoma said to possess specific antigen, when successively maintained for a
long time, is known to lose its specific antitumor activity, as it is converted
to a non-specific antigen (15). For this reason in the elucidation of tumor
immunity it is necessary to use tumor at the early stage of its development.
In the isotransplantation of a tumor to a test animal a mechanism
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similar to the homotransplantation immunity is offered in explaining the
rejection phenomenon on the part of the host (9, 24). Antibodies can
roughly be classified into humoral antibody and cellular antibody, but
the susceptibility to these two antibodies differs with tumors (21). It is
said that tumors like leukemia and lymphoma that have developed in the
hematopoietic organs are markedly susceptible to anti-serum of the host (8),
and sarcoma and cancer cells are poorly susceptible in most cases (2), and
the rejection reaction of the host against sarcoma and cancer cells largely
depends upon the cells of the lymphoid series (4, 10, 14, 24). It is also
reported that in the isotransplantation of lymphoid cells from the superim-
munized antitumorgenic mouse to normal mouse of the same strain in vivo,
antitransplantability is conferred to the recipient animal (3).
KLEIN and co-workers (1960) (5) may be said to be the first who
demonstrated antitumor activity (antitumorgenicity) in the lymphoid
cells of the mouse transplanted with MC-induced sarcoma. YOSHIDA
and SOUTHAM (1963) (7) in their neutralization test with the spleen cells
prepared from the mouse bearing MC-induced sarcoma, found that the
growth of tumor in the host is similarly inhibited by spleen cells. However,
reports on periodical alterations in the antitumorgenicity of lymphoid cells
of cancer-bearing host in vivo are very rare (3, 18, 23). OHSUGI and associ-
ates (1966) (20), using MC-sarcoma induced under the skin on the back of
C3H mouse, performed isotransplantation of MC-induced sarcoma to mice
of the same strain, and preparing periodically regional lymph node cell from
the host by the same technique as in the present experiments conducted
the mixed cultures of tumor cells with these regional lymph node cells in
vitro. They fonnd antitumor activity in these regional lymph-node cells
later than 13 days after the tumor transplantation. ROSENAU and MORTON
(1966) (18) produced subcutaneously MC-induced sarcomas in both hind
legs of C3H and C57BL mice, and using the third to the sixth generation
tumors of the successive isotransplantation they sensitized the animals.
Then they found tumor-specific inhibition of growth of MC-induced
sarcoma in vivo and in vitro by sensitized isologous lymphoid cells prepared
from the spleen of sensitized hosts. As a result they concluded that there
was a close correlation between the inhibitory effect of sensitized lymphoid
cells on tumors in vivo and the suppressive effect of such lymphoid cells on
these neoplasms in tissue culture. As to the studies on the tumor growth
and the antitumor activity of lymphoid cells from the host there are
reports by HARA and SATOH of our laboratory, using tumors other than
MC-induced sarcomas. HARA (1965) (13) studied with lapse of time the
antitumor activity in vitro of senstized lymphoid cells and spleen cells
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obtained from the host sensitized with JTC-II cells (derived from Ehrlich
ascites tumor cells) and found a strong inhibitory effect in vitro on tumor
cell growth by regional lymphoid cells of the host in the first and the
second week after transplantation of JTC-II cells. SATOH (1966) (17) sen-
sitized C3H mice by inoculating subcutaneously on the back with 5 X 106
cells/mouse, using A cells derived from the same strain mammary cancer
and tried the neutralization tests in vitro with regional lymph-node cells
prepared periodically from the host. He found that the regional lymph-
node cells from the host 10 days after transplantation showed the strongest
inhibitory effect on tumor growth, but those lymph-node cells obtained
from the host at the terminal stage of cancer revealed much lower inhibitory
effect.
Similar to the results of these in vitro experiments, in the present study
in vivo using the first and the second transplants of MC-induced sarcomas,
we found that the regional lymph-node cells obtained with lapse of time
from the cancer-bearing hosts at one and two weeks after transplantation
showed a strong inhibitory effect on tumor growth.
From these homo- and isotransplantations of tumors it may be assumed
that the host about 7 days after cancer transplantation considers cancer
antigen as not-self and acts inhibitorily on the tumor growth by way of
the regional lymph-node cells, but when the cancer grows to a certain size
such an inhibitory effect of the host diminishes or disappears. It seems that
such an decrease in the antitumor activity of the host can be recovered to
some extent by removing tumors from the cancer-bearing host. Usually,
the reason why the cancer-bearing animal does not show any inhibitory
effect on tumor growth seems to lie in the fact that the host is immunolo-
gically tolerant to excessive cancer antigens (25) or the immune capacity
of the host has been affected in some way by tumor (21, 22). Another
point to be mentioned is, as demonstrated with MC-induced mouse sarcoma
by BUBENIK and KOLDOVSKY (1965) (27), that the immune response of the
host against tumor is probably altered from growth inhibitory effect to
immunological enhancement. Just as a minute amount of serum antibody,
though somewhat delayed in its appearance, intervenes the approach of
sensitized lymphoid cells, such serum antibody would possibly make a
coating on specific antigens on the surface of tumor cells.
However, as already mentioned in early part of this report with MC-
induced sarcoma of early stage when no aleration would have occurred in
cancer specific antigens, the inhibitory effect in vivo of the cancer-bearing
host on the tumor growth was strong in the regional lymph-node cells
obtained one to two weeks after tumor transplantation but no inhibitory
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effect was observed in the poriod beyond three weeks.
In any event, it is noteworthy that even in the cancer-bearing animal
destined to die of tumors, as a certain stage of cancer, it acts inhibitorily
on the tumor growth through its lymphoid system. It seems that this
antitumor activity is dependent upon such facotrs as the strength of new
tumor antigens altered by cancerization, the potency and degree of anti-
genicity of the host, and the strength of surveillance mechanism of the
host.
CONCLUSION
MC-induced sarcomas produced under the skin on the back between
scapulas of C3H mice were transplanted successively to the mice of the
same strain. Using the first and the second generation tumors, viable
tumor cells were prepared and with these tumor cells C3H mice were
inoculated. From these sensitized mice regional lymph nodes were taken
out at certain intervals and lymph-node cells were prepared. These tumor
cells were mixed with regional lymph-node cells in the ratio of 1 : 10, and
the mixed cells were transplanted subcutaneously on the back of C3H
mice, and the development and growth of tumors were observed at inter-
vals. As a result it was found that the inhibitory effect of these regional
lymph-node cells on the tumor growth was strong one to two weeks after
the transplantation, but beyond 3, or 4 weeks no inhibition was observable.
In connection with the present in vivo experiments, some comments
were made on the available literature, and it has been demonstrated that
even in the cancer-bearing animal destined to die of tumors, at certain
stage of cancer there is seen an inhibitory effect of the host on the tumor
growth by way of the lymphoid system and that such a response of the
host in vivo seems to be correlated well with in vitro reaction.
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